Article

ForbesForbes on 2020-04-16 11:00

South Korea’s Second-Richest Man Adds $2.2 Billion To His Wealth While Battling The Coronavirus Pandemic

Seo Jung-jin’s Celltrion is on track to start human trials of its coronavirus drug in July. Its shares surged 37.6% since March 18, fueled by optimism ...

Related news